• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

玻璃体内注射阿柏西普治疗与牵牛星综合征相关的息肉状脉络膜血管病变。

INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH MORNING GLORY SYNDROME.

机构信息

Department of Surgical Science, Eye Clinic, University of Cagliari, Cagliari, Italy; and.

Clinica Oculistica, San Giovanni di Dio Hospital, Azienda Ospedaliera Universitaria di Cagliari, Cagliari, Italy.

出版信息

Retin Cases Brief Rep. 2020 Summer;14(3):278-281. doi: 10.1097/ICB.0000000000000698.

DOI:10.1097/ICB.0000000000000698
PMID:29324624
Abstract

PURPOSE

To describe an unusual case of polypoidal choroidal vasculopathy secondary to morning glory syndrome successfully treated with three aflibercept intravitreal injections.

METHODS

Case report.

RESULTS

A 68-year-old white man presented with a 2-month history of diminished vision of his left eye. Fundus examination showed a morning glory syndrome disk anomaly with some perimacular subretinal hemorrhages and lipid depositions. Fundus autofluorescence, fluorescein and green indocyanine angiography, spectral domain optical coherence tomography, and optical coherence tomography angiography were performed and confirmed the presence of a juxtapapillary polypoidal choroidal vasculopathy with intraretinal and subretinal fluid. Patient underwent 3 monthly intravitreal injections of aflibercept and at 4-month follow-up visit, multimodal imaging findings did not show any kind of neovascular lesion activity.

CONCLUSION

Polypoidal choroidal vasculopathy can occur in morning glory syndrome and it can be successfully treated with anti-vascular endothelial growth factor intravitreal injections of aflibercept.

摘要

目的

描述一例成功用 3 次康柏西普玻璃体腔注射治疗的与牵牛花综合征相关的息肉样脉络膜血管病变的不常见病例。

方法

病例报告。

结果

一名 68 岁白人男性,左眼视力下降 2 个月。眼底检查显示牵牛花综合征伴有一些黄斑区视网膜下出血和脂质沉积。进行了眼底自发荧光、荧光素和吲哚青绿血管造影、谱域光相干断层扫描和光相干断层扫描血管造影,证实存在伴有视网膜内和视网膜下液的近节段息肉样脉络膜血管病变。患者接受了 3 次每月玻璃体腔内注射康柏西普的治疗,在 4 个月的随访时,多模态成像结果未显示任何新生血管病变活动。

结论

息肉样脉络膜血管病变可发生于牵牛花综合征,且可通过玻璃体腔内注射抗血管内皮生长因子的康柏西普成功治疗。

相似文献

1
INTRAVITREAL AFLIBERCEPT IN THE TREATMENT OF POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH MORNING GLORY SYNDROME.玻璃体内注射阿柏西普治疗与牵牛星综合征相关的息肉状脉络膜血管病变。
Retin Cases Brief Rep. 2020 Summer;14(3):278-281. doi: 10.1097/ICB.0000000000000698.
2
Optic disk melanocytoma associated with polypoidal choroidal vasculopathy lesions, after combination treatment of photodynamic therapy and intavitreal aflibercept (Eylea), a case report.光动力疗法联合玻璃体内注射阿柏西普(阿瓦斯汀)治疗后,视盘黑素细胞瘤合并息肉状脉络膜血管病变:一例报告
BMC Ophthalmol. 2018 Oct 12;18(1):267. doi: 10.1186/s12886-018-0927-7.
3
Timing of Complete Polypoidal Regression after Intravitreous Aflibercept Treatments in Polypoidal Choroidal Vasculopathy.玻璃体内阿柏西普治疗后息肉样脉络膜血管病变完全息肉样消退的时间。
Ophthalmol Retina. 2022 Jan;6(1):21-28. doi: 10.1016/j.oret.2021.03.012. Epub 2021 Mar 27.
4
Initial treatment for polypoidal choroidal vasculopathy: Ranibizumab combined with photodynamic therapy or fixed-dosing aflibercept monotherapy.息肉样脉络膜血管病变的初始治疗:雷珠单抗联合光动力疗法或固定剂量阿柏西普单药治疗。
Eur J Ophthalmol. 2020 Nov;30(6):1473-1479. doi: 10.1177/1120672119871886. Epub 2019 Sep 2.
5
OPTICAL COHERENCE TOMOGRAPHY FEATURES OF POLYPOIDAL LESION CLOSURE IN POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH AFLIBERCEPT.光相干断层扫描在阿柏西普治疗息肉状脉络膜血管病变中对息肉样病变闭合的特征。
Retina. 2022 Jan 1;42(1):114-122. doi: 10.1097/IAE.0000000000003285.
6
Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.阿柏西普治疗性延长方案用于息肉状脉络膜血管病变的两年结果
Graefes Arch Clin Exp Ophthalmol. 2017 Oct;255(10):1891-1897. doi: 10.1007/s00417-017-3718-6. Epub 2017 Jul 1.
7
REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.光动力疗法联合阿柏西普治疗息肉状脉络膜血管病变后脉络膜血管密度降低。
Retina. 2021 Jan 1;41(1):156-161. doi: 10.1097/IAE.0000000000002793.
8
Aflibercept Treatment in Polypoidal Choroidal Vasculopathy: Results of a Prospective Study in a Caucasian Population.阿柏西普治疗息肉样脉络膜血管病变:一项针对高加索人群的前瞻性研究结果
Ophthalmologica. 2018;240(4):208-212. doi: 10.1159/000488808. Epub 2018 May 25.
9
CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.脉络膜厚度作为阿柏西普或雷珠单抗光动力疗法治疗息肉状脉络膜血管病变的预后因素
Retina. 2017 Oct;37(10):1866-1872. doi: 10.1097/IAE.0000000000001427.
10
Intravitreal aflibercept for active polypoidal choroidal vasculopathy without active polyps.玻璃体内阿柏西普治疗无活动性息肉的活动性息肉样脉络膜血管病变。
Sci Rep. 2019 Feb 6;9(1):1487. doi: 10.1038/s41598-018-37523-5.

引用本文的文献

1
An unusual association of Morning Glory Syndrome with chronic myeloid leukemia-Philadelphia chromosome.牵牛花综合征与慢性髓性白血病-费城染色体的罕见关联。
J Family Med Prim Care. 2020 Aug 25;9(8):4456-4459. doi: 10.4103/jfmpc.jfmpc_892_20. eCollection 2020 Aug.